FIELD: medical engineering. SUBSTANCE: device is designed as implants manufactured on the basis of siloxane copolymer of formula or . EFFECT: enhanced effectiveness of prolonged anti-progestine drug release. 15 cl, 5 dwg, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
DRUG PENETRATION RATE-CONTROLLING MEMBRANE OR MATRIX | 1999 |
|
RU2201794C2 |
OTORHINOLOGICAL DELIVERING DEVICE | 2004 |
|
RU2334525C2 |
DRUG DELIVERY SYSTEM | 2002 |
|
RU2302883C2 |
NOVEL MEMBRANE OR MATRIX FOR ADJUSTABLE PENETRATION OF MEDICINAL DRUGS | 1999 |
|
RU2231531C2 |
DELIVERY SYSTEM | 2005 |
|
RU2412693C2 |
USE OF TOCOPHEROL | 2008 |
|
RU2461584C2 |
METHOD FOR PREPARING A DRUG DELIVERY DEVICE AND A DRUG DELIVERY DEVICE MADE BY SAID METHOD | 2016 |
|
RU2732822C2 |
HORMONAL OR ANTI-HORMONAL STEROID COMPOUNDS, METHODS FOR THERAPEUTIC EFFECT, METHOD FOR PREPARING COMPOUNDS | 1999 |
|
RU2238943C2 |
FLEXIBLE, LOW-TEMPERATURE COMPOSITIONS OF FILLED COMPOSITE MATERIAL, COATINGS AND METHODS | 2013 |
|
RU2636274C2 |
APPLICATION OF DONORS OF NITROGEN OXIDE OR INHIBITORS OF NITROGEN OXIDE FOR REGULATION OF UTERUS CERVIX OPENING AND STRETCHING | 1996 |
|
RU2199346C2 |
Authors
Dates
2004-05-10—Published
2000-11-21—Filed